Article info

Download PDFPDF

Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

Authors

  1. Correspondence to Richard P Gale, York Teaching Hospital NHS Foundation Trust, York, YO31 8HE, UK; richard.gale{at}york.nhs.uk
View Full Text

Citation

Gale RP, Pearce I, Eter N, et al
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

Publication history

  • Received March 12, 2019
  • Revised June 12, 2019
  • Accepted July 12, 2019
  • First published August 5, 2019.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.